{
    "2019-01-27": [
        [
            {
                "time": "2023-01-15",
                "original_text": "3 Things You Should Expect in Pfizer's Q4 Earnings Update",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Q4",
                        "Earnings",
                        "Update"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-01-15",
                "original_text": "3 Things You Should Expect in Pfizer's Q4 Earnings Update",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Q4",
                        "Earnings",
                        "Update"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-01-15",
                "original_text": "Pfizer Pivots to Cancer Drugs for Growth",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Cancer",
                        "Drugs",
                        "Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}